2008, Number 583
<< Back Next >>
Rev Med Cos Cen 2008; 65 (583)
Cáncer colonorectal y tamizaje poblacional
Viales LG, Villalobos AJ, Vargas BR
Language: Spanish
References: 19
Page: 119-123
PDF size: 188.10 Kb.
ABSTRACT
Colorectal cancer constitute a health issue at a worldwide and national level. In order to obtain an early detection of the disease, it is recommended for the population over 50 years old to take screening tests. This article will review the generalities on colorectal cancer, besides some of the tendencies and recommendations for the screening of the population.
REFERENCES
American Cancer Society. Cancer Facts & Figures 2007. Atlanta. Ga: American Cancer Society; 2007.
David F.Ransohoff, MD and Robert S. Sandler, MD, MPH. Screening for Colorectal Cancer. N Engl J Med, 2002
John H Scholefield. Screening for colorectal cancer. British Medical Bulletin 2002;64:75—80.
Jürgen Weitz, Moritz Koch, Jürgen Debus, Thomas Höhler, Peter R Galle, Markus W Büchler. Colorectal cancer. Lancet 2005; 365:153—65
Lang A, Ransohoff D. What can we conclude from the randomized controlled trials fecal occult blood test screening. Eur J Gastroenterol Hepatol 1998;10:199-204
L. Paz valiñas, G Atienza Merino. Evaluacion de la eficiencia y efectividad del cribado poblacional del cáncer colorectal. Aplicabilidad en el sistema nacional de Salud. Santiago de Compostela: Servicio Gallego de Gaude. Axencia de Avaliacion de Tecnoloxias Sanitarias de Galicia, avalia-t, 2002.
Mandel JS, Church TR, Ederer F. The effect of fecal occult-blood screening on the incidence of colorectal cancer. New England Journal Med 2001;344:1022-3.
Ministerio de Salud, Dirección vigilancia de la Salud, Unidad de estadística- Registro Nacional de Tumores. Incidencia y Mortalidad del Cáncer en Costa Rica 1990-2003, Dr. Adolfo Ortiz Barboza, Msc Rosia Maria Vargas Alvarado y DipI Georgina Muñoz Leiva.
Pignone M, Rich M, Teutsch SM, Berg AO, Lohr KN. Screening for colorectal cancer in adults at average risk: a summary of the evidence for the U.S. Preventive Services Task Force. Annals of Internal Medicine 2002;137:132—141.
Robert S. Sandler, M.D., M.P.H., Susan Halabi, Ph.D., John A. Baron, M.D., Susan Budinger, B.S., A Randomized Trial of Aspirin to Prevent Colorectal Adenomas in Patients with Previous Colorectal Cancer. N Engl J Med 2003:348:883-90.
Saslow D, Boetes C, Burke W, et al for the American Cancer Society Breast Cancer Advisory Group. American Cancer Society guidelines for breast screening with MRI as an adjunct to mammography. CA Cancer J Clin. 2007;57:75-89.
Sleisenger and Fordtran’s Gastrointestinal and Liver Disease: Pathophysiology, Diagnosis, Management,
Smith RA, Cokkinides V, Lyre HJ. American Cancer Society guidelines for the early detection of cancer, 2006. CA Cancer J Clin. 2006;56:11-25.
Towler B, Irving L, Glasziou P, Kewenter J, WelIer D, Stagy C. A systematic review of the effect of screening for colorectal cancer using the fecal occult blood test, Hemoccult. BMJ 1998; 371:559-65.
U.S. Preventive Services Task Force. Screening for Colorectal Cancer. Rockville, MD: Agency for Healthcare Research Quality; 2002.
WHO Media Centre, Cancer, Fact sheet N°297, February 2006.
Winawer S, Fletcher R, Rex D, Bond J, Burt R, Ferrucci J, Ganiats T, Levin T, Woolf S, Johnson D, Kirk L, Litin S, Simmang C, Gastrointestinal Consortium Panel. Colorectal cancer screening and surveillance: clinical guidelines and rationale. Update based on new evidence. Gastroenterology 2003 Feb;124(2):544-60.
Winawer SJ, Zauber AG: Risñ of correctal cancer in the families of patient with adenomatuos polyps. New England Journa Med 1996;334:82-7.
Yana Vinogradova, Julia Hippisley—Cox, Carol Coupland y Richard F. Logan. Risk of Colorectal Cancer in Patients Prescribed Statins, Nonsteroidal Anti-Inflammatory Drugs, and Cyclooxygenase-2 Inhibitors: Nested Case-Control Study. GASTROENTEROLOGY 2007;133:393—402
Full text